Evaluation | Screening | Enrollment | Time of follow up after surgery (month) | ||||||
---|---|---|---|---|---|---|---|---|---|
3 | 6 | 12 | 18 | 24 | 30 | 36 | |||
Written consent | √ | ||||||||
Inclusion/exclusion criteria | √ | ||||||||
Medical history | √ | ||||||||
Physical exam | √ | ||||||||
Safety test (preoperative examination) | √ | ||||||||
2D/3D-CDUS/MRI | √ | √ | √ | √ | √ | √ | √ | √ | |
FSH, E2, AMH, CA125 | √ | √ | √ | √ | √ | √ | √ | √ | |
Side effects | √ | √ | √ | √ | √ | √ | √ | ||
VAS and NRS | √ | √ | √ | √ | √ | √ | √ | √ | |
SF-36 and FSFI | √ | √ | √ | √ | √ | √ | √ | √ | |
PBAC score | √ | √ | √ | √ | √ | √ | √ | √ |